AR
EXAS

Advisory Research’s Exact Sciences EXAS Stock Holding History

Advisory Research’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,685
Closed -$1.38M – 215
2023
Q4 		$1.38M Sell
18,685
-1,626
-8% -$107K 0.21% 124
2023
Q3 		$1.39M Sell
20,311
-5,742
-22% -$487K 0.19% 146
2023
Q2 		$2.45M Buy
26,053
+10,888
+72% +$849K 0.31% 89
2023
Q1 		$1.03M Sell
15,165
-635
-4% -$40.8K 0.17% 149
2022
Q4 		$782K Buy
+15,800
New +$646K 0.07% 188
2021
Q3 		– Sell
-2,737
Closed -$340K – 377
2021
Q2 		$340K Sell
2,737
-5,360
-66% -$640K 0.02% 299
2021
Q1 		$1.07M Buy
8,097
+1,165
+17% +$159K 0.08% 201
2020
Q4 		$918K Buy
+6,932
New +$838K 0.07% 204
2020
Q3 		– Sell
-4,370
Closed -$380K – 316
2020
Q2 		$380K Sell
4,370
-1,598
-27% -$128K 0.03% 267
2020
Q1 		$346K Sell
5,968
-2,751
-32% -$223K 0.02% 229
2019
Q4 		$806K Buy
8,719
+3,603
+70% +$317K 0.04% 200
2019
Q3 		$462K Buy
5,116
+258
+5% +$29.4K 0.02% 257
2019
Q2 		$573K Sell
4,858
-3,109
-39% -$313K 0.01% 294
2019
Q1 		$690K Sell
7,967
-26,466
-77% -$2.25M 0.01% 266
2018
Q4 		$2.17M Sell
34,433
-13,455
-28% -$923K 0.05% 179
2018
Q3 		$3.78M Sell
47,888
-26,643
-36% -$1.74M 0.06% 160
2018
Q2 		$4.46M Sell
74,531
-19,944
-21% -$1.07M 0.07% 155
2018
Q1 		$3.81M Buy
94,475
+12,561
+15% +$613K 0.07% 163
2017
Q4 		$4.3M Sell
81,914
-31,948
-28% -$1.71M 0.07% 158
2017
Q3 		$5.37M Sell
113,862
-39,229
-26% -$1.58M 0.09% 149
2017
Q2 		$5.42M Buy
153,091
+83,917
+121% +$2.59M 0.09% 148
2017
Q1 		$1.63M Buy
+69,174
New +$1.37M 0.02% 275
2015
Q4 		– Sell
-32,500
Closed -$585K – 284
2015
Q3 		$585K Buy
+32,500
New +$747K 0.01% 242

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisory Research's EXAS Position: Q1 2024 in Review

Advisory Research sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 18,685 shares — an estimated $1.38M sold.

Advisory Research first reported a position in EXAS in Q3 2015 and held it in 23 quarters. The position peaked at $5.42M in Q2 2017. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Advisory Research reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Advisory Research sold 18,685 Exact Sciences shares in Q1 2024, an estimated $1.38M.
  • Advisory Research first reported a position in Exact Sciences in Q3 2015 and held it in 23 quarters.
  • Advisory Research's Exact Sciences position peaked at $5.42M in Q2 2017.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.